Cordis Sequicor Theta Models 233D & 233E
by Telectronics Pacing Systems, Inc.
PMA P820014
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP820014 | Date11 Jun 1985 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Implantable pulse generator, pacemaker (non-CRT)
- PMA Number
- FDA Product Code
- LWP
- Device Class
- Class III
- Advisory Committee
- Cardiovascular
- FDA Decision
- APPR Approved
- PMA Supplement
- S017
Overview
AI-generated summary, 18 Sep 2026
The Cordis Sequicor Theta Models 233D & 233E are implantable pulse generators classified as non-CRT pacemakers. These devices are designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when abnormal electrical activity is detected, ensuring consistent and appropriate cardiac pacing.
These pacemakers are intended for surgical implantation and are regulated under an FDA Premarket Approval (PMA). Supplied sterile and single-use, they are categorized under product code LWP and are authorized under PMA number P820014 with supplement S024. The devices are manufactured by Telectronics Pacing Systems, Inc., now part of Medtronic, and are intended for use in clinical settings requiring cardiac rhythm management.
Other devices from Telectronics Pacing Systems, Inc.
Questions
AI-generated answers, 18 Sep 2026
Are the Cordis Sequicor Theta Models 233D & 233E designed for patients requiring cardiac resynchronization therapy (CRT)?
No, these devices are explicitly classified as non-CRT pacemakers. They are intended to regulate heart rhythm by delivering electrical impulses to the heart muscle when abnormal electrical activity is detected, but they are not designed for biventricular pacing or cardiac resynchronization therapy.
How are the Cordis Sequicor Theta Models 233D & 233E supplied, and are they reusable?
The devices are supplied sterile and are intended for single-use only. They are not designed for reuse, which is consistent with their classification as implantable pulse generators requiring surgical implantation.
What regulatory pathway was followed for the approval of these devices, and what is the associated PMA number?
The Cordis Sequicor Theta Models 233D & 233E were approved through the FDA’s Premarket Approval (PMA) process, which is required for Class III devices like implantable pulse generators. The primary PMA number is P820014, with a supplement noted as S024.
Are there different models available within the Cordis Sequicor Theta series, and if so, how do they differ?
Yes, the series includes Models 233D and 233E, though the provided data does not specify technical differences between them. Both are classified under the same generic name (Implantable Pulse Generator, Pacemaker) and product code (LWP), so distinctions would require additional manufacturer documentation.
What is the intended clinical setting for use of the Cordis Sequicor Theta Models 233D & 233E?
These devices are intended for use in clinical settings requiring cardiac rhythm management, specifically for surgical implantation to regulate heart rhythm in patients with abnormal electrical activity. They are not intended for home use or non-surgical applications.